TRIB: trinitybiotech.com Projected Price to Earnings

The forward P/E ratio dynamics reflect the current growth trajectory of Trinity Biotech plc (TRIB), which relies on external logistics for test delivery. Growth is driven by distributor partnerships and the acquisition of IT solutions for diabetics. Global sales of consumables for HIV and infection diagnostics provide a stable revenue stream. The 0.00 indicator captures the value of this parameter on the chart.

Market Cap to Projected Earnings: Trinity Biotech plc (TRIB) for 07/04/2022 - 11/10/2026

Analytical breakdowns and data insights for company Trinity Biotech Corp (TRIB)

- stock value and consensus price forecast:

Price Chart Trinity Biotech plc|TRIB - Price Target Chart

- market capitalization information:

Market Valuation Trinity Biotech PLC|TRIB - Total Enterprise Value

- issuer book value statistics:

Net Assets per Single Share Trinity Biotech|TRIB - Book Valuation of Business|Market Capitalization to Book Value Ratio trinitybiotech.com|TRIB - Company Total Asset Base

- debt level and financial liquidity data:

Debt to Equity Trinity Biotech plc|TRIB - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Equity Ratio Trinity Biotech plc|TRIB - Company Cumulative Indebtedness|Debt to Book Capitalization Ratio Trinity Biotech PLC|TRIB - Company Long-Term Loans and Borrowings|Company Short-Term Debts Trinity Biotech|Quick Liquidity trinitybiotech.com

- company profitability and valuation multiples indicators:

TRIB - Company Profit|Projected Future Earnings Trinity Biotech plc|TRIB - Business Payback Period|Projected Price to Earnings Trinity Biotech plc|TRIB - Company Value to Earnings Growth Ratio|Enterprise Value to EBITDA Ratio Trinity Biotech PLC|TRIB - Profit before interest, taxes and amortization|Net earnings per share for the last 12 months Trinity Biotech|TRIB - Earnings per share for the trailing year|Quarterly EPS earnings growth trinitybiotech.com|TRIB - Earnings per share growth in current year|Earnings growth forecast for next year Trinity Biotech plc

Summary company analysis:TRIB Trinity Biotech

The forward P/E reflects the market value of Trinity Biotech plc (TRIB) relative to projected earnings per share, allowing for an assessment of the asset's fair value based on expected cash flows. By analyzing the company's forward P/E history, an investor can compare the growth rates of rapid hemoglobin diagnostics with market expectations to determine whether they are overpaying for the issuer's dominance in the portable analyzer niche.

Direct competitors